VVOS · Vivos Therapeutics, Inc. · Held by Funds
$0.15
+0.00 (+1.52%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, we had approximately $1.8 million in cash and cash equivalents, which will not be sufficient to fund operations and strategic objectives over the next twelve months from the date of the issuance of these financial statements. Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.83M
Shares
20.12M
Volume · Oct 5
585.84K
Avg daily vol (3M)
12.34M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding VVOS
5 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | FSMAX | 60,769 | $42,538 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 60,629 | $27,556 | 0.00% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 12,072 | $8,450 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 8,350 | $5,845 | 0.00% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 4,300 | $1,954 | 0.00% | Short | 2026-06-30 |
Showing 1–5 of 5 positions